Compare Medpace Holdings Inc (MEDP) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Royal Bank of Canada — how do they compare? Medpace Holdings Inc trades at $530.22 (market cap $15.08B), while Royal Bank of Canada trades at $210.37 (market cap $289.51B). The key difference: Royal Bank of Canada is far larger — about 19.2× Medpace Holdings Inc's market cap, and Royal Bank of Canada pays a 2.42% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | RY | |
|---|---|---|
Market Cap | $15.08B | $289.51B |
Sector | Technology | Financials |
52-Week High | $620.59 | $217.87 |
52-Week Low | $308.88 | $128.46 |
Enterprise Value | $14.55B | — |
Dividend Yield | — | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
